A closer look at the technologies used by Yescarta
Yescarta
Blood & Organ Banks · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.yescartatecartusrems.comRevenue
<$5 MillionIndustry
About Yescarta
Kite Pharma is dedicated to curing cancer through innovative cell therapy technologies. The company focuses on developing CAR T-cell therapies, which are custom-made treatments designed to harness patients' immune systems to target and attack specific types of blood cancer. Kite Pharma's pipeline includes research aimed at improving patient responses to cell therapy and enhancing manufacturing processes. Their intended clients are patients diagnosed with various forms of blood cancer seeking advanced treatment options.Explore more
SIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Yescarta
Compare insights from companies similar to Yescarta, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Yescarta
<$5M
11-50
Private
-
-
N/A
Yescarta Tech Stack
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Yescarta
Sign Up For FreeTo access detailed company insights
Kite Pharma is dedicated to curing cancer through innovative cell therapy technologies. The company focuses on developing CAR T-cell therapies, which are custom-made treatments designed to harness patients' immune systems to target and attack specific types of blood cancer. Kite Pharma's pipeline includes research aimed at improving patient respons... Read More
